MTNB icon

Matinas BioPharma
MTNB

Overview Fund Activity

67 hedge funds and large institutions have $33.5M invested in Matinas BioPharma in 2021 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 9 reducing their positions, and 13 closing their positions.

Holders
67
Holders Change
–
Holders Change %
0%
% of All Funds
1.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
21
Reduced
9
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SIG
1
Sargent Investment Group
Maryland
$4.22M
2
AWA
2
Arkadios Wealth Advisors
Georgia
$1.82M
3
VF
3
Virtu Financial
New York
$300K
4
CCM
4
Courage Capital Management
Tennessee
$2.21M
5
Citadel Advisors
5
Citadel Advisors
Florida
$241K

Top Sellers

1
BC
1
Boxer Capital
California
$0
2
GCP
2
GSA Capital Partners
United Kingdom
$967K
3
Victory Capital Management
3
Victory Capital Management
Texas
$39K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$0
5
Hudson Bay Capital Management
5
Hudson Bay Capital Management
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Squarepoint
76
Squarepoint
New York
– -$12K -322 Closed
FDCDDQ
77
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$11.9K -306 Closed
OAM
78
Occidental Asset Management
California
– -$9K -240 Closed
Susquehanna International Group
79
Susquehanna International Group
Pennsylvania
– -$9K -239 Closed
Franklin Resources
80
Franklin Resources
California
– -$8K -200 Closed
1 2 3
4